Business context and reporting period
SkinHealth Systems Inc. filed this Form 8-K to report results of its virtual special stockholders’ meeting held September 22, 2026. The report was signed September 28, 2026. The filing reports voting matters, not quarterly or annual financial results.
Key financial information
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or financial outlook figures.
Meeting results and material developments
- At the August 3, 2026 record date, 130,140,763 shares of Class A common stock were outstanding. Holders of 115,893,322 shares were present or represented by proxy, approximately 89.05%, establishing a quorum.
- Reverse stock split approved: Stockholders approved an amendment authorizing a reverse split at a ratio between 1-for-5 and 1-for-20. The board may select the exact ratio within that range. Votes: 114,398,602 for; 1,406,150 against; 88,570 abstentions.
- Adjournment proposal approved: Stockholders approved authority to adjourn the meeting if needed to solicit additional proxies or establish a quorum. Votes: 114,344,814 for; 1,450,597 against; 97,911 abstentions.
- The filing does not state that the reverse split has been implemented or specify its effective date. No comparable-period financial changes are reported.
Outlook, risks, and unusual items
No financial guidance, management outlook, or specific contingencies are provided. The principal corporate action disclosed is the authorization for a reverse stock split; its final ratio and implementation remain for the board to determine.
Investor verification points
- Check subsequent filings for the board-selected split ratio and effective date.
- Verify how the split will affect outstanding shares, trading, and any applicable fractional-share treatment.
- Review the August 12, 2026 definitive proxy statement for the proposals’ full terms.